Wednesday, August 22nd, 2012...12:38 am

Q2 2012 Drug Sales Data Released: Loss of Patent Protection Has Significant Effect

The latest U.S. drug sales data has been released by Drugs.com. Proton-pump inhibitors, antipsychotics, asthma therapeutics and statins remain the top selling categories. Plavix and Seroquel dipped in the second quarter due to loss of patent protection. Other top brands such as Singulair, Actos and Diovan are also due to be impacted by year’s end.

Visit the data here…
http://www.drugs.com/stats/top100/sales

View the press release here…
http://www.drugs.com/news/latest-top-100-sales-data-released-loss-patent-protection-has-significant-39870.html

Leave a Reply